Ethic Inc. Astrazeneca PLC Transaction History

Ethic Inc.

$3.97 Billion
Q3 2024

A detailed history of Ethic Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Ethic Inc. holds 91,133 shares of AZN stock, worth $5.87 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

91,133

Previous 107,740 15.41%

Holding current value

$5.87 Million

Previous $8.4 Million 15.48%

% of portfolio

0.18%

Previous 0.2%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$76.67 - $87.62 $1.27 Million - $1.46 Million	-16,607 Reduced 15.41%	91,133 $7.1 Million
Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $1.11 Million - $1.34 Million	16,607 Added 18.22%	107,740 $8.4 Million
Q1 2024 May 13, 2024	BUY	$61.03 - $69.57 $253,762 - $289,272	4,158 Added 4.78%	91,133 $6.17 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $519,504 - $581,536	8,394 Added 10.68%	86,975 $5.86 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $222,305 - $245,787	3,428 Added 4.56%	78,581 $5.32 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $55,298 - $59,965	791 Added 1.06%	75,153 $5.38 Million
Q1 2023 May 12, 2023	SELL	$63.15 - $71.6 $305,267 - $346,114	-4,834 Reduced 6.1%	74,362 $5.16 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $615,717 - $800,057	11,358 Added 16.74%	79,196 $5.37 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $203,808 - $521,823	-3,844 Reduced 5.36%	67,838 $3.72 Million
Q2 2022 Aug 10, 2022	BUY	$59.26 - $71.14 $489,665 - $587,829	8,263 Added 13.03%	71,682 $4.74 Million
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $1.4 Million - $1.68 Million	25,070 Added 65.37%	63,419 $4.21 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $31,277 - $36,957	-579 Reduced 1.49%	38,349 $2.23 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $687,277 - $751,972	12,370 Added 46.58%	38,928 $2.34 Million
Q2 2021 Aug 10, 2021	BUY	$48.42 - $60.18 $295,991 - $367,880	6,113 Added 29.9%	26,558 $1.59 Million
Q1 2021 May 13, 2021	BUY	$47.16 - $54.44 $109,977 - $126,954	2,332 Added 12.87%	20,445 $1.02 Million
Q4 2020 Feb 10, 2021	BUY	$48.52 - $58.02 $172,488 - $206,261	3,555 Added 24.42%	18,113 $905,000
Q3 2020 Oct 27, 2020	BUY	$53.07 - $61.1 $107,519 - $123,788	2,026 Added 16.17%	14,558 $798,000
Q2 2020 Aug 12, 2020	BUY	$43.1 - $55.31 $105,293 - $135,122	2,443 Added 24.21%	12,532 $663,000
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $79,812 - $108,408	2,112 Added 26.48%	10,089 $451,000
Q4 2019 May 22, 2020	BUY	$42.46 - $50.46 $81,098 - $96,378	1,910 Added 31.48%	7,977 $398,000
Q4 2019 Feb 13, 2020	BUY	$42.46 - $50.46 $257,604 - $306,140	6,067 New	6,067 $303,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.

Account